Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 95 articles: HTML format Text format

Single Articles

January 2012
1. KWON MJ , Park S, Choi JY, Oh E, et al
   Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.
   Br J Cancer. 2012 Jan 31. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. YAGHJYAN L , Mahoney MC, Succop P, Wones R, et al
   Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.
   Br J Cancer. 2012 Jan 26. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MOHAMMED ZM , McMillan DC, Elsberger B, Going JJ, et al
   Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
   Br J Cancer. 2012;106:383-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BRAIN E , Isambert N, Dalenc F, Dieras V, et al
   Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BERGHOFF A , Bago-Horvath Z, De Vries C, Dubsky P, et al
   Brain metastases free survival differs between breast cancer subtypes.
   Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. COX RF , Hernandez-Santana A, Ramdass S, McMahon G, et al
   Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation.
   Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TSANG RY , Finn RS
   Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer.
   Br J Cancer. 2012;106:6-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HARRIS HR , Bergkvist L, Wolk A
   Alcohol intake and mortality among women with invasive breast cancer.
   Br J Cancer. 2012 Jan 3. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
9. SIDON L , Ingham S, Clancy T, Clayton R, et al
   Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.
   Br J Cancer. 2011 Dec 20. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. CARDINALE F , Bruzzi P, Bolognesi C
    Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.
    Br J Cancer. 2011 Dec 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LO NIGRO C , Vivenza D, Monteverde M, Lattanzio L, et al
    High frequency of complex TP53 mutations in CNS metastases from breast cancer.
    Br J Cancer. 2011 Dec 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PAYNE RE , Hava NL, Page K, Blighe K, et al
    The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.
    Br J Cancer. 2011 Dec 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. BYRD PJ , Srinivasan V, Last JI, Smith A, et al
    Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia.
    Br J Cancer. 2011 Dec 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PARKIN DM
    15. Cancers attributable to reproductive factors in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S73-6.
    PubMed     Text format     Related articles   
    
    
    
    
15. PARKIN DM
    10. Cancers attributable to exposure to hormones in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S42-8.
    PubMed     Text format     Related articles   
    
    
    
    
16. PARKIN DM
    9. Cancers attributable to inadequate physical exercise in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S38-41.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
17. BARTSCH R , Berghoff A, Pluschnig U, Bago-Horvath Z, et al
    Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.
    Br J Cancer. 2011 Nov 29. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. WEBSTER RM , Abraham J, Palaniappan N, Caley A, et al
    Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network.
    Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KARIHTALA P , Kauppila S, Puistola U, Jukkola-Vuorinen A, et al
    Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype.
    Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ROMANO S , Fratini S, Ricevuto E, Procaccini V, et al
    Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.
    Br J Cancer. 2011 Nov 8. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BALAKRISHNAN A , Ravichandran D
    Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy.
    Br J Cancer. 2011 Nov 8. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ABRAMOVITZ M , Barwick BG, Willis S, Young B, et al
    Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
    Br J Cancer. 2011;105:1574-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. DAVIES NJ , Batehup L, Thomas R
    The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature.
    Br J Cancer. 2011;105 Suppl 1:S52-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. KHAN NF , Mant D, Carpenter L, Forman D, et al
    Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.
    Br J Cancer. 2011;105 Suppl 1:S29-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HARLID S , Ivarsson MI, Butt S, Grzybowska E, et al
    Combined effect of low-penetrant SNPs on breast cancer risk.
    Br J Cancer. 2011 Nov 1. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
26. STEVENS KN , Garcia-Closas M, Fredericksen Z, Kosel M, et al
    Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
    Br J Cancer. 2011 Oct 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. LUNDIN KB , Henningson M, Hietala M, Ingvar C, et al
    Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.
    Br J Cancer. 2011 Oct 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LEONARD R , Ballinger R, Cameron D, Ellis P, et al
    Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?
    Br J Cancer. 2011;105:1260-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SAHEBJAM S , Aloyz R, Pilavdzic D, Brisson ML, et al
    Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score.
    Br J Cancer. 2011;105:1342-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BRAIN E , Levy C, Serin D, Roche H, et al
    High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.
    Br J Cancer. 2011 Oct 18. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. FORBES LJ , Atkins L, Thurnham A, Layburn J, et al
    Breast cancer awareness and barriers to symptomatic presentation among women from different ethnic groups in East London.
    Br J Cancer. 2011 Oct 11. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
32. PARVINEN I , Chiu S, Pylkkanen L, Klemi P, et al
    Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland.
    Br J Cancer. 2011 Sep 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. PRONK A , Ji BT, Shu XO, Chow WH, et al
    Physical activity and breast cancer risk in Chinese women.
    Br J Cancer. 2011 Sep 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SHAO R , Cao QJ, Arenas RB, Bigelow C, et al
    Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.
    Br J Cancer. 2011 Sep 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BUCK K , Zaineddin AK, Vrieling A, Heinz J, et al
    Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. WALKER K , Bratton DJ, Frost C
    Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SWERDLOW AJ , Jones ME, Schoemaker MJ, Hemming J, et al
    The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CHAIWUN B , Sukhamwang N, Trakultivakorn H, Saha B, et al
    GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SUDHAGAR S , Sathya S, Lakshmi BS
    Rapid non-genomic signalling by 17beta-oestradiol through c-Src involves mTOR-dependent expression of HIF-1alpha in breast cancer cells.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PANDYA K , Meeke K, Clementz AG, Rogowski A, et al
    Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.
    Br J Cancer. 2011;105:796-806.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
41. OSAKO T , Iwase T, Kimura K, Yamashita K, et al
    Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method.
    Br J Cancer. 2011 Aug 30. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. ZHANG M , Holman CD
    Low-to-moderate alcohol intake and breast cancer risk in Chinese women.
    Br J Cancer. 2011 Aug 9. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. OPDAHL S , Alsaker MD, Janszky I, Romundstad PR, et al
    Joint effects of nulliparity and other breast cancer risk factors.
    Br J Cancer. 2011 Aug 2. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
44. REIMAN A , Srinivasan V, Barone G, Last JI, et al
    Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.
    Br J Cancer. 2011 Jul 26. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. PAQUETTE B , Therriault H, Desmarais G, Wagner R, et al
    Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor.
    Br J Cancer. 2011 Jul 26. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. VINOGRADOVA Y , Coupland C, Hippisley-Cox J
    Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies.
    Br J Cancer. 2011;105:452-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LADOIRE S , Arnould L, Mignot G, Apetoh L, et al
    T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival.
    Br J Cancer. 2011;105:366-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. RAVINDRANATH A , Yuen HF, Chan KK, Grills C, et al
    Wnt-beta-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer.
    Br J Cancer. 2011 Jul 19. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KEY TJ , Appleby PN, Reeves GK, Roddam AW, et al
    Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.
    Br J Cancer. 2011 Jul 19. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. PERVIN S , Tran A, Tran L, Urman R, et al
    Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.
    Br J Cancer. 2011 Jul 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. PEASLAND A , Wang LZ, Rowling E, Kyle S, et al
    Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.
    Br J Cancer. 2011 Jul 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
52. MILLAR EK , Graham PH, McNeil CM, Browne L, et al
    Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.
    Br J Cancer. 2011 Jun 28. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. RING A , Reed M, Leonard R, Kunkler I, et al
    The treatment of early breast cancer in women over the age of 70.
    Br J Cancer. 2011 Jun 21. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. AKSLEN LA , Straume O, Geisler S, Sorlie T, et al
    Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.
    Br J Cancer. 2011 Jun 14. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. GLOVER JA , Hughes CM, Cantwell MM, Murray LJ, et al
    A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FORBES LJ , Linsell L, Atkins L, Burgess C, et al
    A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
57. BORRIELLO M , Laccetti P, Terrazzano G, D'Alessio G, et al
    A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours.
    Br J Cancer. 2011;104:1716-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ALLGOOD PC , Duffy SW, Kearins O, O'Sullivan E, et al
    Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.
    Br J Cancer. 2011;104:1680-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MOLLOY TJ , Devriese LA, Helgason HH, Bosma AJ, et al
    A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CALDON LJ , Collins KA, Wilde DJ, Ahmedzai SH, et al
    Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer.
    Br J Cancer. 2011;104:1551-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. JEREVALL PL , Ma XJ, Li H, Salunga R, et al
    Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. LEE HE , Kim JH, Kim YJ, Choi SY, et al
    An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MUNSTER PN , Thurn KT, Thomas S, Raha P, et al
    A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
64. HUIART L , Dell'aniello S, Suissa S
    Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
65. WADDELL T , Kotsori A, Constantinidou A, Yousaf N, et al
    Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. THOMAS ZI , Gibson W, Sexton JZ, Aird KM, et al
    Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. YOKDANG N , Tellez JD, Tian H, Norvell J, et al
    A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. METCALFE K , Gershman S, Lynch HT, Ghadirian P, et al
    Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. YIP NC , Fombon IS, Liu P, Brown S, et al
    Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. BERNATSKY S , Ramsey-Goldman R, Foulkes WD, Gordon C, et al
    Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. PASHAYAN N , Duffy SW, Chowdhury S, Dent T, et al
    Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. PEETERS DJ , Van den Eynden GG, van Dam PJ, Prove A, et al
    Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
73. MAZOUNI C , Fina F, Martin PM
    Reply: Is Epstein-Barr virus associated with aggressive forms of breast cancer?
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
74. KHAN G , Philip PS, Al Ashari M
    Is Epstein-Barr virus associated with aggressive forms of breast cancer?
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
75. SYED BM , Al-Khyatt W, Johnston SJ, Wong DW, et al
    Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. GEE HE , Buffa FM, Camps C, Ramachandran A, et al
    The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.
    Br J Cancer. 2011;104:1168-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. GEISLER J
    Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?
    Br J Cancer. 2011;104:1059-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. PAGE K , Hava N, Ward B, Brown J, et al
    Detection of HER2 amplification in circulating free DNA in patients with breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. DUANMU J , Cheng J, Xu J, Booth CJ, et al
    Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. STEMMLER HJ , Digioia D, Freier W, Tessen HW, et al
    Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ROSELL J , Nordenskjold B, Bengtsson NO, Fornander T, et al
    Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
    Br J Cancer. 2011;104:899-902.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. DE GELDER R , Draisma G, Heijnsdijk EA, de Koning HJ, et al
    Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
83. SOUTHEY MC , Ramus SJ, Dowty JG, Smith LD, et al
    Morphological predictors of BRCA1 germline mutations in young women with breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. VAN SCHOOR G , Moss SM, Otten JD, Donders R, et al
    Increasingly strong reduction in breast cancer mortality due to screening.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. ALI AM , Greenberg D, Wishart GC, Pharoah P, et al
    Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England.
    Br J Cancer. 2011;104:564-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. HUTTON J , Walker LG, Gilbert FJ, Evans DG, et al
    Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.
    Br J Cancer. 2011;104:578-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. YUN J , Kim KH, Kang ES, Gwak GY, et al
    Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. BENNETT RL , Sellars SJ, Moss SM
    Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. MADSEN M , Andersen PK, Gerster M, Nybo Andersen AM, et al
    Does the association of education with breast cancer replicate within twin pairs? A register-based study on Danish female twins.
    Br J Cancer. 2011;104:520-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
90. ALI AM , Dawson SJ, Blows FM, Provenzano E, et al
    Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. WONG CS , Lim GH, Gao F, Jakes RW, et al
    Mammographic density and its interaction with other breast cancer risk factors in an Asian population.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MICHLMAYR A , Bachleitner-Hofmann T, Bergmann M, Oehler R, et al
    Reply: Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
93. GARANTZIOTIS S
    Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
94. O'CONNOR M , Christensen S, Jensen AB, Moller S, et al
    How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. BREWSTER DH , Clark DI, Stockton DL, Munro AJ, et al
    Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007.
    Br J Cancer. 2011;104:60-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: